GeneDx Corp. (WGSWW)
NASDAQ: WGSWW
· Real-Time Price · USD
0.06
-0.00 (-3.85%)
At close: Jun 09, 2025, 3:38 PM
Company Description
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services.
The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights.
It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening.
GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
GeneDx Corp.

Country | United States |
IPO Date | n/a |
Industry | Medical - Healthcare Information Services |
Sector | Healthcare |
Employees | 1,000 |
CEO | Katherine A. Stueland |
Contact Details
Address: North Tower Stamford, Delaware United States | |
Website | https://www.genedx.com |
Stock Details
Ticker Symbol | WGSWW |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | 0001818331 |
CUSIP Number | n/a |
ISIN Number | US81663L1199 |
Employer ID | 85-1966622 |
SIC Code | 8000 |
Key Executives
Name | Position |
---|---|
Katherine A. Stueland | President, Chief Executive Officer & Director |
Dr. Bryan M. Dechairo Ph.D. | Chief Operating Officer |
Heidi C. Chen J.D. | Chief Legal Officer |
Kevin Feeley CPA | Chief Financial Officer |
Dr. Martin G. Reese Ph.D. | President of Fabric Genomics |
Jami Biliboaca | Head of People Strategy |
Melanie Duquette | Chief Growth Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 03, 2025 | 4 | Filing |
May 16, 2025 | 4 | Filing |
May 12, 2025 | 4 | Filing |
May 12, 2025 | SCHEDULE 13G | Filing |
May 09, 2025 | 4/A | [Amend] Filing |
May 09, 2025 | SCHEDULE 13G/A | [Amend] Filing |
May 07, 2025 | SCHEDULE 13D/A | [Amend] Filing |
May 06, 2025 | 4 | Filing |
May 05, 2025 | 4 | Filing |
May 01, 2025 | 4 | Filing |